Romoli Michele, Migliaccio Ludovica, Saia Valentina, Pracucci Giovanni, Cirillo Luigi, Forlivesi Stefano, Romano Daniele, Casetta Ilaria, Fainardi Enrico, Sallustio Fabrizio, Limbucci Nicola, Nencini Patrizia, Da Ros Valerio, Diomedi Marina, Vallone Stefano, Bigliardi Guido, Vinci Sergio Lucio, La Spina Paolino, Bergui Mauro, Cerrato Paolo, Bracco Sandra, Tassi Rossana, Saletti Andrea, Azzini Cristiano, Ruggiero Maria, Castellan Lucio, Benzi Markushi Tiziana, Menozzi Roberto, Pezzini Alessandro, Lazzarotti Guido Andrea, Giannini Nicola, Castellano Davide, Naldi Andrea, Comai Alessio, Dall'Ora Elisa, Plebani Mauro, Cappellari Manuel, Frauenfelder Giulia, Puglielli Edoardo, Casalena Alfonsina, Burdi Nicola, Boero Giovanni, Nappini Sergio, Loizzo Nicola Davide, Cavasin Nicola, Critelli Adriana, Ivaldi Diego, Tassinari Tiziana, Biraschi Francesco, Nicolini Ettore, Zimatore Sergio, Petruzzellis Marco, Filauri Pietro, Orlandi Berardino, Gallesio Ivan, Ferrandi Delfina, Pavia Marco, Invernizzi Paolo, Amistá Pietro, Russo Monia, Paladini Adriana, Rizzo Annalisa, Besana Michele, Giossi Alessia, Filizzolo Marco, Mannino Marina, Mangiafico Salvatore, Toni Danilo, Zini Andrea
Neurology and Stroke Unit, Department of Neurosciences, Bufalini Hospital, Cesena, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Bologna, Italy.
Eur Stroke J. 2024 Nov 20:23969873241299335. doi: 10.1177/23969873241299335.
Data on safety and efficacy of endovascular thrombectomy (EVT) for acute ischemic stroke in older patients are limited and controversial, and people aged 80 or older were under-represented in randomized trials. Our aim was to assess EVT effect for ischemic stroke patients aged ⩾80 at a nationwide level.
The cohort included stroke patients undergoing EVT from the Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS). Patients were a priori divided into younger and older groups (<80 vs ⩾80). Primary outcome was good functional outcome (modified Rankin scale, mRS, 0-2 at 90 days). Secondary outcomes were symptomatic intracranial hemorrhage (sICH), successful reperfusion, EVT abortion. Propensity score matching (PSM) was performed between age groups for baseline features, functional status, stroke severity and neuroradiological features. Logistic regression was implemented to test the weight of age group on the predefined outcomes.
Overall, 5872 individuals (1:1 matching, = 2936 aged ⩾80 vs = 2936 < 80) were matched from 13,922 records. In ⩾80 group 34.1% had good functional outcome, vs 51.2% in <80 group (absolute difference = -17.1%, < 0.001), with a 4.4% excess in EVT abortion. Age ⩾80 was a negative independent predictor of good functional outcome (aOR = 0.4, 95% CI = 0.3-0.5), but had no impact on sICH.
Age ⩾80 years represents a consistent predictor of worse functional outcome, independently from successful reperfusion and sICH. Cost-effectiveness studies are needed for tailored and implement sustainable care, and research should focus on strategies to improve functional outcome in older age patient groups.
关于老年患者急性缺血性卒中血管内血栓切除术(EVT)安全性和有效性的数据有限且存在争议,80岁及以上的人群在随机试验中的代表性不足。我们的目的是在全国范围内评估EVT对80岁及以上缺血性卒中患者的疗效。
该队列包括来自意大利急性卒中血管内治疗注册中心(IRETAS)接受EVT的卒中患者。患者被预先分为年轻组和老年组(<80岁与≥80岁)。主要结局是良好的功能结局(改良Rankin量表,mRS,90天时为0 - 2)。次要结局是症状性颅内出血(sICH)、成功再灌注、EVT中止。对年龄组之间的基线特征、功能状态、卒中严重程度和神经放射学特征进行倾向评分匹配(PSM)。采用逻辑回归来检验年龄组对预定义结局的影响。
总体而言,从13922条记录中匹配出5872例个体(1:1匹配,n = 2936例年龄≥80岁 vs n = 2936例<80岁)。在≥80岁组中,34.1%有良好的功能结局,而<80岁组为51.2%(绝对差异 = -17.1%,P < 0.001),EVT中止率高出4.4%。年龄≥80岁是良好功能结局的负性独立预测因素(调整后比值比 = 0.4,95%置信区间 = 0.3 - 0.5),但对sICH无影响。
80岁及以上是功能结局较差的一致预测因素,与成功再灌注和sICH无关。需要进行成本效益研究以制定并实施可持续的护理方案,并且研究应聚焦于改善老年患者群体功能结局的策略。